Related Experiment Videos
Challenging cases in thyroid cancer: a multidisciplinary approach
Michael Tuttle1, Richard Robbins, Steven M Larson
1Endocrine Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA. tuttlem@mskcc.org
European Journal of Nuclear Medicine and Molecular Imaging
|December 11, 2003
Summary
Recurrent thyroid cancer often resists radioiodine therapy. Multidisciplinary teams are crucial for managing complex cases, including radioiodine-refractory metastases and unresectable recurrences.
Area of Science:
- Oncology
- Nuclear Medicine
- Head and Neck Surgery
Background:
- Recurrent thyroid cancer presents complex management challenges, frequently becoming refractory to standard radioiodine therapy.
- Effective regional control of localized recurrences necessitates strategic use of external beam irradiation and surgical interventions.
Observation:
- Patients with widespread, radioiodine-refractory bone metastases from follicular thyroid cancer require specialized management.
- Unresectable central neck recurrence of papillary thyroid cancer poses significant treatment difficulties.
Findings:
- A multidisciplinary team approach, integrating thyroid medicine, surgery, head and neck radiotherapy, and nuclear medicine, is essential for optimal patient care.
- Individualized, multimodality treatment recommendations are best developed through collaborative expert consensus.
Implications:
- This approach optimizes treatment strategies for challenging recurrent thyroid cancer cases.
- It highlights the necessity of specialized expertise for managing refractory disease and complex recurrences.